معرفی
Dr. Arief Lalmohamed is an Associate Professor of Pharmacoepidemiology at Utrecht University's School of Pharmacy, where he also heads the Clinical Drug Trials department at UMC Utrecht. He obtained his MSc Pharmacy (2010) and PhD (2014) from Utrecht University, both cum laude. His research bridges clinical pharmacoepidemiology, drug safety, and drug repurposing, with applications in oncology, immunology, and critical care therapeutics.
Research focuses include:
- Real-world drug safety and efficacy evaluations
- Therapeutic drug monitoring (e.g., busulfan/chemotherapy)
- Drug repurposing strategies
- Pharmacoepidemiology of autoimmune/rheumatic diseases
- Critical care pharmacology and sustainability
His 50+ publications show strong trends in oncology pharmacotherapy (35%), transplant medicine (25%), and drug safety methodologies (20%), with recent emphasis on antibiotic stewardship, ICU drug management, and precision dosing.
Awards and honors:
- NWO Mosaic Grant (€200,000)
- Cum laude distinctions for MSc and PhD
- Teaching award nominations
He supervises 6 PhD students and leads clinical trial oversight for 300+ annual studies at UMC Utrecht. As METC committee member, he has reviewed 100+ clinical protocols. Educational leadership includes chairing Utrecht University's MSc Oncology course and co-developing interprofessional learning platforms.
